Guide

What research use only actually means

Almost every supplier in this category writes the phrase. Rather fewer let it constrain anything they do. Here is what it should mean in practice.

Written by [[CONTENT AUTHOR NAME]]Reviewed by [[SCIENTIFIC REVIEWER NAME]], [[REVIEWER CREDENTIALS]]Updated July 28, 2026Editorial policy

Research use only means the material is supplied for laboratory research and is not a drug, food, supplement, cosmetic or medical device. It is not a disclaimer added for cover — it is a description of the basis of supply, and it commits the supplier to behaviour, not just to a sentence in the footer.

It describes the supply, not just the label

Research use only is a statement about what a material is being offered as. The same peptide offered for human consumption is being offered as an unapproved drug, regardless of what the footer says. So the phrase is only meaningful if the supplier's actual conduct matches it.

That is a testable proposition, and it is worth testing on any supplier you are considering.

What it commits a supplier to

No claim that a material diagnoses, treats, cures, mitigates or prevents anything.
No dosing, administration or reconstitution guidance for human or animal use, in any channel — not in copy, not in support email, not in a direct message.
No grouping of the catalogue by what compounds are for, because a therapeutic category implies a therapeutic use.
No human-experience framing: no testimonials, no before-and-after, no reviews describing effects.
No purity figure that is not on a certificate, because an unbacked number is a claim.

What it asks of the purchaser

A declaration, recorded with the wording shown and the date accepted, that the material is for laboratory research use only. And responsibility for lawful purchase and possession, for safe handling and disposal under the purchaser's own institutional requirements, and for determining that a material suits the research intended.

The declaration is not a checkbox to get past. It is the document that makes the basis of supply explicit on both sides.

What it does not mean

It does not mean lower quality. Research-use material can be, and should be, characterised to a standard that makes its properties known — identity confirmed, purity measured by a named method, net content quantified, results attributable to a named laboratory and to a specific lot.

It also does not mean the supplier can be vague. The opposite: because no claim about effect is permitted, the only thing left to compete on is the analytical record. That is a good constraint.

How to tell whether a supplier means it

Look for what is absent. A compliant catalogue has no therapeutic categories, no dosing charts, no reviews describing how something felt, and no purity figure floating free of a lot number. Look also for what is present: certificates that name the issuing laboratory, open without an account, and change when the lot changes.

A supplier that will not answer a question it is not permitted to answer is showing you how it operates.

Common questions

Does research use only mean the peptide is low grade?

No. It describes the intended use and regulatory basis of supply. Quality is evidenced separately, by the analytical record for the specific lot.

Why will a compliant supplier not give reconstitution guidance?

Because reconstitution guidance is preparation guidance for administration, and providing it would recast a research supply as the promotion of an unapproved drug. Storage and handling of sealed material is a separate question and can be answered.

Why does the catalogue have no categories?

Because grouping compounds by research area implies what they are for, and implying a use is the thing research-use-only supply excludes. Grouping by structure — single compound or blend, chemical class — carries no such implication.